💨 Abstract

Bioventus Inc. reported a second-quarter net income of $7.5 million, reversing a loss from the previous year. The company achieved $147.7 million in revenue. Adjusted earnings were 21 cents per share. Bioventus forecasts full-year earnings between 64 to 68 cents per share and revenue between $560 million and $570 million.

Courtesy: WTOP Staff